Epcoritamab User Reviews & Ratings

• Ste...
• Taken for 1 to 2 years
• August 21, 2024

For Diffuse Large B-Cell Lymphoma "Epcor has been working great, and infusion is so easy. No PICC line, no port. In and out. Side effects I've noticed are fatigue (take naps), brain fog (cleared up with citicoline), tingling in hands and feet (I used benfotiamine), rash around mouth (cannon balm 140)."

• Mik...
• Taken for 6 months to 1 year
• December 30, 2024

For Follicular Lymphoma "Lower energy, muscular/skeletal pain and soreness. Weight gain. Although that could be a result of less mobility due to tiredness. Higher triglycerides. Yuck feeling during weekly injections. Now every two somewhat better. Knees and ankles feel weaker too. Now, the good news. My NHL is in complete remission. Didn't take long either. Gotta do the trial..."

• SRY...
• Taken for 6 months to 1 year
• July 1, 2025

For Follicular Lymphoma "I've been on Epcoritamab for 7 months. I got a total metabolic response at my 3-month scan. I was having a weekly injection, then fortnightly, now monthly. Three days after the injection, the injection site gets red, hot, and very sore. I get severe neck and lower back pain. My joints are also sore, and my skin is tender to touch. Symptoms last for about 4 days and then disappear, until the next injection. I'm managing at home with strong pain relief, I'm an otherwise healthy 45-year-old."

• Cll...
• Taken for 6 months to 1 year
• September 25, 2024

"I get treatments at MSK for almost a year, and my cancer has not come back. All my results, like PET, CT, MRI, and blood work, are excellent."

• Ano...
• Taken for 6 months to 1 year
• June 9, 2025

For Follicular Lymphoma "Some digestive problems. (Minor). Sore necks. Swelling at injection site for a few days. Got CR in 3 months."

• jud...
• Taken for 6 months to 1 year
• March 29, 2024

For Diffuse Large B-Cell Lymphoma "For the most part, it's ok. I have stomach trouble, am extremely tired, have little appetite, red marks on my skin, and low hemoglobin levels."